Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of Graves' ophthalmopathy

Thyroid

Volumn 13, Issue 7, 2003, Pages 653-658

  Moleti, Mariacarla ^a   Mattina, Filiberto ^a   Salamone, Ignazio ^a   Violi, Maria Antonia ^a   Nucera, Carmelo ^a   Baldari, Sergio ^a   Lo Schiavo, Maria Grazia ^a   Regalbuto, Concetto ^b   Trimarchi, Francesco ^a   Vermiglio, Francesco ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; RADIOACTIVE IODINE; THIAMAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ACTIVITY SCORE; CONTROLLED STUDY; DIFFERENTIATED THYROID CARCINOMA; ENDOCRINE OPHTHALMOPATHY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; THYROID SURGERY; THYROIDECTOMY;

EID: 10744231097     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503322240004     Document Type: Article

References (22)

1. Burch H, Wartofsky L 1993 Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev 14:747-793.
2. Tallstedt L, Lundell G 1997 Radioiodine treatment, ablation and ophthalmopathy: A balanced perspective. Thyroid 7:241-245.
3. De Groot LJ, Benjasuratwong Y 1996 Evaluation of thyroid ablative therapy for ophthalmopathy of Graves' disease. Orbit 15:187-196.
4. De Groot LJ 1997 Radioiodine and the immune system. Thyroid 7:259-264.
5. Tallstedt L, Lundell G, Törring O, Wallin G, Ljunggren JG, Blomgren H, Taube A, and the Thyroid Study Group 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 326:1733-1738.
6. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relationship between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78.
7. Mourits MP, Koorneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R 1989 Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 73:639-644.
8. Mourits MP, Prummel MF, Wiersinga WM, Koorneef L 1997 Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol 47:9-14.
9. Prummel MF, Wiersinga WM, Mourits MP, Koorneef L, Berghout A, van der Gaag R 1990 Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med 150:1098-1101.
10. Sridama V, De Groot LJ 1989 Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 87:70-73.
11. Marcocci C, Bartalena L, Bogazzi F, Bruno Bossio G, Pinchera A 1992 Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism. Thyroid 2:171-178.
12. Bartalena L, Pinchera A, Marcocci C 2000 Management of Graves' ophthalmopathy: Reality and perspectives. Endocr Rev 21:168-199.
13. Prummel MF, Wiersinga WM, Mourits MP, Koorneef L, Berghout A, van der Gaag R 1989 Amelioration of eye changes of Graves' ophthalmopathy by achieving euthyroidism. Acta Endocrinol 121(suppl 2):185-189.
14. Volpe R 1994 Evidence that the immunosuppressive effects of antithyroid drugs are mediated through actions on thyroid cell, modulating thyrocyte-immunocyte signaling: A review. Thyroid 2:217-223.
15. Törring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Sääf M, Hamberger B, and the Thyroid Study Group 1996 Graves' hyperthyroidism: Treatment with antithyroid drugs, surgery or radioiodine. A prospective, randomized study. J Clin Endocrinol Metab 81:2986-2993.
16. Pinchera A, Bartalena L, Marcocci C 1995 Radioiodine may be bad for Graves' ophthalmopathy, but... J Clin Endocrinol Metab 80:342-344.
17. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A 1989 Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321:1349-1362.
18. Winsa B, Rastad J, Akerstrom G, Johansson H, Westermark K, Karlsson FA 1995 Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy. Eur J Endocrinol 132:406-412.
19. Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A 1996 Surgical treatment of Graves' disease: Subtotal or total thyroidectomy? Surgery 120:1020-1025.
20. Catz B, Perzik SL 1969 Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease. Am J Surg 118:434-439.
21. Marcocci C, Bartalena L, Pinchera A 1998 Ablative or nonablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy? J Endocrinol Invest 21:468-471.
22. Marcocci C, Bruno Bossio G, Manetti L, Tanda ML, Miccoli P, Iacconi P, Bartolomei MP, Nardi M, Pinchera A, Bartalena L 1999 The course of Graves' opthalmopathy is not influenced by near total thyroidectom: A case control study. Clin Endocrinol 51:503-508.